Skip to content

PTHS PTHS Commercial operations — Total Assets

Other segment segments

Research and Development operations
$1.1M

Similar metrics at other companies

Envela logo
ELACommercial — Total Assets
$20.85M-38.0%
StoneX Group Inc. logo
SNEXCommercial — Total Assets
$10.9B+95.7%
St. Joe Company logo
JOECommercial — Total Assets
$492.33M-4.4%
Pathward Financial, Inc. logo
CASHCommercial — Total Assets
$4.51B+13.5%
The Bancorp logo
TBBKCommercial — Total Assets
$1.75B+2.4%
Western Alliance Bancorporation logo
WALCommercial Segment — Total Assets
$35.58B+8.3%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's commercial operations — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's commercial operations — total assets?
PTHS (PTHS) reported commercial operations — total assets of $144.28M in Q1 2026.
What does commercial operations — total assets mean?
This metric represents the total value of resources, including inventory, accounts receivable, and segment-specific equipment, controlled by the commercial operations segment. It reflects the capital intensity required to support the distribution and sales of therapeutic products. Monitoring these assets provides insight into the operational infrastructure and capital allocation efficiency within the commercial division.